제이피아이헬스케어
Financials
Valuation Metrics
제이피아이헬스케어's Market Cap is ₩459B. Ranked #1799 of 2,436 in KR market (top 74%), #1099 of 1,649 on KOSDAQ (top 67%), #199 of 234 in Pharmaceuticals, Biotechnology & Life Sciences (top 85%) by Market Cap.
Investment Metrics(as of 2026-08-04)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 45.90B KRW | KR#1,799/2,436 Sec#199/234 |
| Revenue | 48.47B KRW | KR#1,797/2,436 Sec#123/234 |
| Net Income | 4.84B KRW | KR#1,134/2,436 Sec#77/234 |
| Total Assets | 82.38B KRW | KR#1,891/2,436 Sec#158/234 |
| Net Assets | 63.05B KRW | KR#1,714/2,436 Sec#148/234 |
| Value | ||
| P/E | 9.48x | KR#675/2,436 Sec#34/234 |
| P/B | 0.73x | KR#1,176/2,436 Sec#65/234 |
| P/S | 0.95x | KR#1,362/2,436 Sec#79/234 |
| EV/EBITDA | 10.19x | KR#610/2,436 Sec#28/234 |
| FCF Yield | 4.54% | KR#895/2,436 Sec#47/234 |
| Profitability | ||
| ROE | 7.68% | KR#726/2,436 Sec#47/234 |
| ROA | 5.88% | KR#543/2,436 Sec#42/234 |
| Op. Margin | 10.03% | KR#490/2,436 Sec#46/234 |
| Financial Health | ||
| Debt Ratio | 130.65% | KR#866/2,436 Sec#99/234 |
| Total Debt | 10.98B KRW | KR#1,592/2,436 Sec#145/234 |
| FCF | 2.09B KRW | KR#1,078/2,436 Sec#76/234 |
| Cash | 7.36B KRW | KR#1,836/2,436 Sec#158/234 |
| Current Ratio | 7.52x | KR#169/2,436 Sec#40/234 |
| Net Debt/EBITDA | 0.74x | KR#773/2,436 Sec#51/234 |
| Dividend | ||
| Div. Yield | 2.87% | KR#680/2,436 Sec#35/234 |
| Performance | ||
| 1M Return | 25.03% | KR#94/2,436 Sec#4/234 |
| From 52W High | -70.03% | KR#2,140/2,436 Sec#193/234 |
| 1Y MDD | -69.21% | KR#1,919/2,436 Sec#164/234 |
| Trading | ||
| Volume | 12,455 shares | KR#2,048/2,436 Sec#203/234 |
| Foreign Own. | 1.47% | KR—/2,436 Sec—/234 |
| Per Share | ||
| EPS | 1,149 KRW | KR#573/2,436 Sec#40/234 |
| BPS | 12,547 KRW | KR#789/2,436 Sec#56/234 |
Company Info
JPI Healthcare, a small and medium-sized venture company established in 1980 and renamed in 2010, specializes in the development and manufacturing of X-ray-based imaging diagnostic core components, including grids and various imaging devices. The company produces and sells next-generation medical imaging equipment such as digital X-ray medical imaging devices, digital tomosynthesis, and mobile low-dose, high-precision CT systems. Its products are supplied to over 300 global companies, including GE, Siemens, and Philips. JPI Healthcare is headquartered in Guro-gu, Seoul Metropolitan City.